Cytomorphometric Evaluation of Oral Mucosa of Patients with Duchenne Muscular Dystrophy

[1]  I. Chiodini,et al.  Osteoporosis and Fragility Fractures in Type 2 Diabetes , 2020, Journal of diabetes research.

[2]  M. Gallottini,et al.  Medication-Related Osteonecrosis of the Jaw in a Duchenne Muscular Dystrophy Patient. , 2020, Photodiagnosis and photodynamic therapy.

[3]  T. Papamitsou,et al.  Bisphosphonate’s Effect on Tongue Mucosa: An Experimental Electron Microscopy Study , 2020, Medicina.

[4]  Fabienne Egli,et al.  Growing patients with Duchenne muscular dystrophy: longitudinal changes in their dentofacial morphology and orofacial functional capacities , 2018, European journal of orthodontics.

[5]  B. Blackwood,et al.  Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy. , 2017, The Cochrane database of systematic reviews.

[6]  S. T. Harris,et al.  Relationship Between Gastrointestinal Events and Compliance With Osteoporosis Therapy: An Administrative Claims Analysis of the US Managed Care Population. , 2016, Clinical therapeutics.

[7]  E. Çankaya,et al.  Changes in Exfoliative Cell of Oral Mucosa in Kidney Transplant Patients. , 2015, Transplantation proceedings.

[8]  A. Simões,et al.  Ultrastructural and biochemical analysis of the effects of alendronate on salivary glands of young rats. , 2014, Archives of oral biology.

[9]  S. Hallikerimath,et al.  Cytomorphometric Analysis and Assessment of Periodic Acid Schiff Positivity of Exfoliated Cells from Apparently Normal Buccal Mucosa of Type 2 Diabetic Patients , 2011, Acta Cytologica.

[10]  E. Palomo Atance,et al.  [Alendronate treatment of osteoporosis secondary to Duchenne muscular dystrophy]. , 2011, Anales de pediatria.

[11]  R. Finkel,et al.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management , 2010, The Lancet Neurology.

[12]  T. Sollecito,et al.  Oral health considerations in muscular dystrophies. , 2008, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.

[13]  S. Cremers,et al.  Inhibition of oral mucosal cell wound healing by bisphosphonates. , 2008, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[14]  Bernard Dan,et al.  Pathophysiology of duchenne muscular dystrophy: current hypotheses. , 2007, Pediatric neurology.

[15]  B. Petrof.  The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy , 1998, Molecular and Cellular Biochemistry.

[16]  T. M. Cestari,et al.  Exfoliative cytology of the oral mucosa in type II diabetic patients: morphology and cytomorphometry. , 2003, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[17]  Amith K Nayar,et al.  Cytomorphometric analysis of exfoliated normal buccal mucosa cells. , 2003, Indian journal of dental research : official publication of Indian Society for Dental Research.

[18]  H. Sweeney,et al.  Dystrophin protects the sarcolemma from stresses developed during muscle contraction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.